Lynn Malec – The New Director of the CCBD and Pharmacy at Children’s Wisconsin
Versiti Inc shared on LinkedIn:
”Versiti is proud to announce the promotion of Lynn Malec, MD, MSc, to Program Director of the Comprehensive Center for Bleeding Disorders (CCBD) and Pharmacy at Children’s Wisconsin.
Since joining Versiti in 2016, Dr. Malec has led transformative advances in bleeding disorder care, including launching our gene therapy program for hemophilia B, which made Versiti one of the first centers in the U.S. to administer the FDA-approved therapy HEMGENIX.
Her internationally recognized research and compassionate leadership continue to expand access to breakthrough treatments and whole-person care for patients and families.
Learn more about our commitment to advancing hope through science.”
More winner stories featured in Hemostasis Today.
-
Dec 19, 2025, 13:30PPTA Europe’s Holiday Message: Wishing Health, Rest, and Renewal for 2026
-
Dec 19, 2025, 13:22If You Were Reading a “Bible for Blood Donation Volunteers,” What’s the ONE Thing That Must Be in It?
-
Dec 19, 2025, 12:52Julia Owens: Stroke Remains One of the World’s Leading Causes of Death and Disability
-
Dec 19, 2025, 12:03Pradeep Natarajan: Our New Genetic Study of Aortic Stenosis in ~3M
-
Dec 19, 2025, 11:47ESO Blog: Anna Gardin on Stroke Risk in the Era of Climate Extremes
-
Dec 19, 2025, 10:51Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
-
Dec 19, 2025, 10:08Camilla Lombardi Shares an EHC Nutrition Guide for People with Bleeding Disorders
-
Dec 19, 2025, 09:56Danny Hsu Shares The ”I-WISh” Study by Nichola Cooper on ITP
-
Dec 19, 2025, 09:39Paul Bolaji: A Landmark Achievement -The Historic 1st Nigerian Stroke Leaders’ Summit 2025